Follow-on roundup: Myovant, CytomX, Spero

Myovant Sciences Ltd. (NYSE:MYOV), CytomX Therapeutics Inc. (NASDAQ:CTMX) and Spero Therapeutics Inc. (NASDAQ:SPRO) each priced follow-ons late Thursday, raising a total of $275 million.

Myovant raised $75 million through the sale of 3.3 million shares at

Read the full 353 word article

User Sign In